Molecular pathogenesis of non-Hodgkin's lymphoma: The role of Bcl-6

被引:105
作者
Pasqualucci, L [1 ]
Bereschenko, O [1 ]
Niu, HF [1 ]
Klein, U [1 ]
Basso, K [1 ]
Guglielmino, R [1 ]
Cattoretti, G [1 ]
Dalla-Favera, R [1 ]
机构
[1] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA
关键词
non-Hodgkin's lymphoma; diffuse large B-cell lymphoma; somatic hypermutation; pathogenesis; Bcl-6; germinal center;
D O I
10.1080/10428190310001621588
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-Hodgkin's lymphomas (NHL) form a heterogeneous group of diseases, with diffuse large B-cell lymphoma (DLBCL) comprising the largest subgroup. The commonest chromosomal translocations found in DLBCL are those affecting band 3q27. In 35% of DLBCL cases, as well as in a small fraction of follicular lymphomas, the normal transcriptional regulation of Bcl-6 is disrupted by these chromosomal translocations. In addition, about three-quarters of cases of DLBCL display multiple somatic mutations in the 5' non-coding region of Bcl-6 , which occur independently of chromosomal translocations and appear to be due to the IgV-associated somatic hypermutation process. Bcl-6 is a 95-kD nuclear phosphoprotein belonging to the BTB/POZ (bric-a-brac, tramtrack, broad complex/Pox virus zinc finger) zinc finger family of transcription factors. It has been suggested that Bcl-6 is important in the repression of genes involved in the control of lymphocyte activation, differentiation, and apoptosis within the germinal center, and that its down-regulation is necessary for normal B-cells to exit the germinal center. Bcl-6 remains constitutively expressed in a substantial proportion of B-cell lymphomas. Recently, acetylation has been identified as a mode for down-regulating Bcl-6 activity by inhibition of the ability of Bcl-6 to recruit complexes containing histone deacetylases (HDAC). The pharmacologic inhibition of two recently identified deacetylation pathways, HDAC- and silent information regulator (SIR)-2-dependent deacetylation, results in the accumulation of inactive acetylated Bcl-6 and thus in cell cycle arrest and apoptosis in B-cell lymphoma cells. These results reveal a new method of regulating Bcl-6 , with the potential for therapeutic exploitation. These studies also indicate a novel mechanism by which acetylation promotes transcription, not only by modifying histones and activating transcriptional activators, but also by inhibiting transcriptional repressors.
引用
收藏
页码:S5 / S12
页数:8
相关论文
共 70 条
[1]   MYC ONCOGENE ACTIVATION IN B-LYMPHOID AND T-LYMPHOID TUMORS [J].
ADAMS, JM ;
CORY, S .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1985, 226 (1242) :59-72
[2]   BCL-6 expression during B-cell activation [J].
Allman, D ;
Jain, A ;
Dent, A ;
Maile, RR ;
Selvaggi, T ;
Kehry, MR ;
Staudt, LM .
BLOOD, 1996, 87 (12) :5257-5268
[3]   Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases [J].
Barlev, NA ;
Liu, L ;
Chehab, NH ;
Mansfield, K ;
Harris, KG ;
Halazonetis, TD ;
Berger, SL .
MOLECULAR CELL, 2001, 8 (06) :1243-1254
[4]   IDENTIFICATION OF THE GENE ASSOCIATED WITH THE RECURRING CHROMOSOMAL TRANSLOCATIONS T(3,14)(Q27,Q32) AND T(3,22)(Q27,Q11) IN B-CELL LYMPHOMAS [J].
BARON, BW ;
NUCIFORA, G ;
MCCABE, N ;
ESPINOSA, R ;
LEBEAU, MM ;
MCKEITHAN, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :5262-5266
[5]   Acetylation inactivates the transcriptional repressor BCL6 [J].
Bereshchenko, OR ;
Gu, W ;
Dalla-Favera, R .
NATURE GENETICS, 2002, 32 (04) :606-613
[6]   DNA double-strand breaks in immunoglobulin genes undergoing somatic hypermutation [J].
Bross, L ;
Fukita, Y ;
McBlane, F ;
Démollière, C ;
Rajewsky, K ;
Jacobs, H .
IMMUNITY, 2000, 13 (05) :589-597
[7]   BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS [J].
CATTORETTI, G ;
CHANG, CC ;
CECHOVA, K ;
ZHANG, JD ;
YE, BH ;
FALINI, B ;
LOUIE, DC ;
OFFIT, K ;
CHAGANTI, RSK ;
DALLAFAVERA, R .
BLOOD, 1995, 86 (01) :45-53
[8]   BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor [J].
Chang, CC ;
Ye, BH ;
Chaganti, RSK ;
DallaFavera, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (14) :6947-6952
[9]   BCL-2 FAMILY: Regulators of cell death [J].
Chao, DT ;
Korsmeyer, SJ .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :395-419
[10]  
Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO